Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4

Journal of Clinical Investigation

Volumn 104, Issue 10, 1999, Pages 1449-1457

  Peakman, Mark ^a,g   Stevens, Elizabeth J ^a   Lohmann, Tobias ^a   Narendran, Parth ^b   Dromey, James ^c   Alexander, Angela ^d   Tomlinson, Andrew J ^e   Trucco, Massimo ^d   Gorga, Joan C ^d,f   Chicz, Roman M ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e Zycos Inc   (United States)

^f Ares Advanced Technology   (United States)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MASS SPECTROMETRY; PANCREAS ISLET CELL; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0032701129     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7936     Document Type: Article

References (50)

1. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:287-299.
2. Zerva, L., et al. 1996. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J. Exp. Med. 183:829-836.
3. Cramp, M.E., et al., 1998. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 29:207-213.
4. 4+ T cell responses in antitumor immunity. Curr. Opin. Immunol. 10:588-594.
5. Czarnecki, D., Nicholson, I., Tait, B., and Nash, C. 1993. HLA DR4 is associated with the development of multiple basal cell carcinomas and malignant melanoma. Dermatology. 187:16-18.
6. Hammer, J., Torniolo, T., and Sinigaglia, F. 1997. HLA class II peptide binding specificity and autoimmunity. Adv. Immunol. 66:67-100.
7. Wucherpfennig, K.W., and Strominger, J.L. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705.
8. Collins, E.J., and Frelinger, J.A. 1998. Altered peptide ligand design: altering immune responses to class I MHC/peptide complexes. Immunol. Rev. 163:151-160.
9. Davenport, M.P., and Hill, A.V. 1996, Reverse immunogenetics: from HLA-disease associations to vaccine candidates. Mol. Med. Today. 2:38-45.
10. Watts, C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:821-50.
11. Chicz, R.M., et al. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 358:764-768.
12. Bartnes, K., Leon, F., Briand, J.P., Travers, P.J., and Hannestad, K. 1999. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-21-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively. Eur. J. Immunol. 29:189-195.
13. Carson, R.T., Desai, D.D., Vignali, K.M., and Vignali, D.A. 1999. Immunoregulation of Th cells by naturally processed pepride antagonists. J. Immunol. 162:1-4.
14. Carson, R.T., Vignali, K.M., Woodland, D.L., and Vignali, D.A. 1997. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity. 7:387-399.
15. Castano, L., and Eisenbarth, G.S. 1990. Type-1 diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8:647-679.
16. She, J.X. 1996. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol. Today, 17:323-329.
17. Leslie, R.D., Atkinson, M.A., and Notkins, A.L. 1999. Autoantigens IA-2 and GAD in type 1 (insulin-dependent) diabetes. Diabetologia. 42:3-14.
18. Kawasaki, E., et al. 1997. Evaluation of islet cell antigen (ICA) 512/1A-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs. J. Clin. Endocrinol. Metab. 82:375-380.
19. Christie, M.R., et al. 1994. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes. 43:1254-1259.
20. Faas, S.J., Menon, R., Braun, E.R., Rudert, W.A., and Trucco, M. 1996. Sequence-specific priming and exonuclease-released fluorescence detection of HLA-DQB1 alleles. Tissue Antigens. 48:97-112.
21. Payton, M., Hawkes, C.J., and Christie, M.R. 1995. Relationship of the 37,000 and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96:1506-1511.
22. Stevens, E.J., and Peakman, M. 1998. Enhanced T cell proliferation and increased responder frequency following delivery of antigen to the antigen presenting cell; B cell dependency and use in detection of autoreactive T cells. J Immunol. Methods. 215:59-70.
23. Chilson, O.P., and Kelly-Chilson, A.E. 1989. Mitogenic lectins bind to the antigen receptors on human lymphocytes. Eur. J. Immunol. 19:389-396.
24. Peakman, M., et al. 1994. T cell clones generated from patients with Type 1 diabetes using interleukin-2 proliferate to human islet antigens. Autoimmunity. 17:31-39.
25. Gorga, J.C., Horejsi, V., Johnson, D.R, Raghupathy, R., and Sttominger, J.L. 1987. Purification and characterization of class II histocompatibility antigens from a homozygous B cell line. J. Biol. Chem. 262:16087-16094.
26. Chicz, R.M., et al. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:24-47.
27. Chicz, R.M., Graziano, D.F, Trucco, M., Strominger, J.L., and Gorga, J.C. 1997. HLA-DP2; self peptide sequences and binding properties. J. Immunol. 159:4935-4942.
28. Honeyman, M.C., Stone, N.L., and Harrison, L.C. 1998. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol. Med. 4:231-239.
29. Lohmann, T., et al. 1999. T cell reactivity to DR*0401 and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes. Exp. Clin. Endocrinol. Diabetes, 107:166-171.
30. Hammer, J., et al. 1994. Precise prediction of major histocompatibility complex class II peptide interactions based on side chain scanning. J. Exp. Med. 180:2353-2358.
31. Marsh, S.G. 1998. HLA class II region sequences. Tissue Antigens. 51:467-507,
32. Roep, B.O., et al. 1996. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur. J. Immunol. 26:128-1289.
33. Harrison, L.C., et al. 1993. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet. 341:136-1369.
34. Honeyman, M.C., Brusic, V., Stone, N.L., and Harrison, L.C. 1998. Neural network-based prediction of candidate T-cell epitopes. Nat. Biotechnol. 16:966-969.
35. Liu, G.Y., et al. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:407-415.
36. Endl, J., et al. 1997. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99:240-2415.
37. Vincent, A., and Willcox, N. 1994. Characterization of specific T cells in myasthenia gravis. Immunol. Today. 15:41-42.
38. Nagvekar, N., et al. 1999. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor. J. Immunol. 162:4079-4087
39. Stevens, E.J., and Peakman, M. 1997. T-cell studies in insulin dependent diabetes mellitus: lessons from other autoimmune diseases. Diabetes. Nutr. Metab. 10:242-254.
40. Rudensky, A.Y., Preston-Hurlburt, P., Hong, S.C, Barlow, A., and Janeway, CA. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature. 353:622-627.
41. Demotz, S., Grey, H.M., Appella, E., and Sette, A. 1989. Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme. Nature. 342:682-684.
42. Vignali, D.A., Urban, R.G., Chicz, R.M., and Strominger, J.L. 1993. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 23:1602-1607.
43. Richter, W., Shi, Y., and Baekkeskov, S. 1993. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localised in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA. 90:2832-2836.
44. Tremble, J., et al., 1997. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. J. Clin. Endocrinol. Metab. 82:2664-2670.
45. Phelps, R.G., Turner, A.N., and Rees, A.J. 1996. Direct identification of naturally processed autoantigen-derived peptides bound to HLA-DR15*. J. Biol. Chem. 271:18549-18553.
46. Marrack, P., Ignatowicz, L., Kappler, J.W., Boymelm, J., and Freed, J.H. 1993. Comparison of peptides bound to spleen and thymus class II. J. Exp. Med. 178:2173-2183.
47. Lohmann, T., et al. 1994. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet. 43:1607-1608.
48. Atkinson, M.A., et al. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94:2125-2129.
49. g7, which is also protective against the development of autoimmune diabetes. Diabetologia. 42:560-565.
50. Crawford, F., Kozono, H., White, J., Marrack, P., and Kappler, J. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 8.675-682.